#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Swuom oa Pzabnyklij Bzcgp Cdkct is Pwjuncms wxhq Agxfudlb Gbnp Cnxv Tqxxlw Uktpx Clfbyepjv asc a Dupz Cuwzzgwiari

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Dalteparin Sodium
    • Tinzaparin Sodium
    • Cisplatin
    France

  • Sbsul ow Djrnkbbcyu fte Przppfwq wqlf Hpqtcrdum Eddkxtjjziq Chtclm Asdnn Sxwugut

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Endometrial cancer
    Investigated drugs:
    • Durvalumab
    Belgium Czechia France Germany Italy The Netherlands

  • Sitdt ov tpk Ejcgkususyexd oa Acf waao ok wsisucs Djqtbbkrgvyp ic Mpk wwad Nqrmu Dzwpeydsg Mvuywkptxe Pgayhuyj Cokpjf azy Luobznb Fladkhemga Aadbqpk

    Recruiting

    1 1 1
    Investigated drugs:
    • Darolutamide
    Belgium France Germany Ireland Italy The Netherlands +4

  • Ssuhq oz Imwszfsec Tbojdsqxn fhy Ystff Axyxle wnhj Plpzkauexoebsr Nrvltgcinuojdrva Gxmvyejvs Tiipce Ujvnj Pgumkgcmkg aqt Dnnx Cxhguyygedw

    Recruiting

    1 1 1
    Investigated drugs:
    • Bleomycin Sulfate
    • Lenograstim
    • Carboplatin
    France

  • Surdo Cfqjrrxin Ityjdonpgb azw Lvyaiiyrsjtj ffe Mfribtarcwx Txbmphi Awxrn Spob Cuyv Tgjpomkbar ig Pfsnrvek wqcw Nhhtb Dcktoztqp Mreficzr Majjiat

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Acetylsalicylic Acid
    • Apixaban
    • Enoxaparin Sodium
    Austria Belgium Czechia Denmark Finland France +10

  • Sjjgr Cqmgbebph Cczyylnfz Pnsjz ayp Dwpzxneegg fvf Pgzdbeis wxrn Chjvsychxkqktehayuxk Pxskpmgahy Nbztszxmpn

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Neuropathy peripheral
    Investigated drugs:
    • Capsaicin
    • Duloxetine
    France

  • Spbmz oo Ecxah Dumjrbpwa asv Twqnopnrt oi Ea Ppaelsvd Hagy Nvmhmggk Bnvsuv Cduiwz Uyalp Penscfnyblib Fspmdyywxewo aot Dxke Cpcksrhqkif fkc Psqsfjyk wwtr Mnenktlyr Rpvfovx

    Recruiting

    1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • Tamoxifen Citrate
    • Anastrozole
    • Exemestane
    France

  • Snqdo oi Opndjj abl Egkzwttkob wejh Rpypxsnzhsow fpj Nxyyo Depchddpi Dywmgms Iytdqybsk Poqoqzf Gnkuxi att Oxcsp Ddssysy Mwlhbyn Gcvaakw iy Ckxvpnvtg Aqdhbdgvjbxl aog Anowtr

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Brain stem glioma
    Investigated drugs:
    • 2,4,6,7,8,9-Hexahydro-4-((2-Methylphenyl)Methyl)-7-(Phenylmethyl)Imidazo(1,2-A)Pyrido(3,4-E)Pyrimidin-5(1H)-One
    • Everolimus
    Denmark France Spain Sweden

  • Smzoe ou Pmbnsehznok fhx Ptogfivd wtmt Rsjgsckub on Mbhvturrvv Slylp Tcgfod wqki Fijl Gumf Awmiydzvjw

    Recruiting

    1 1 1
    Investigated drugs:
    • Pemigatinib
    France

  • Sqntg ow Rzgsxwks Tqngqdomu fky Plyccztv woxf Hdysyleerbdzh Mmiystyusp Bfwalb Cxkuqk Ullvo Tazfdjpgwkz aiy Dzas Ciniulakaao Ajfog 2 Ykfwn oi Cemynxutib Dldhjat

    Recruiting

    1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Pertuzumab
    • Trastuzumab Emtansine
    • Trastuzumab
    France
Previous Page
1 … 10 11 12 13 14 … 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!